To assess the efficacy and safety of bivalirudin during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in high‐bleeding‐risk elderly patients. Click to show full abstract
To assess the efficacy and safety of bivalirudin during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in high‐bleeding‐risk elderly patients.
               
Click one of the above tabs to view related content.